, Journal of Neural Transmission, vol.110, pp.517-536
The genetics of Caenorhabditis elegans, Genetics, vol.77, pp.71-94, 1974. ,
Clinical and laboratory features of the Nocardia spp. based on current molecular taxonomy, Clinical Microbiology Reviews, vol.19, pp.259-282, 2006. ,
Investigating bacterial sources of toxicity as an environmental contributor to dopaminergic neurodegeneration, PLOS ONE, vol.4, 2009. ,
Aging in the nervous system of Caenorhabditis elegans, Communicative & Integrative Biology, vol.6, issue.5, 2013. ,
Environmental toxins and Parkinson's disease, Annual Review of Pharmacology and Toxicology, vol.54, 2014. ,
A comparison of Nocardia asteroides and Nocardia brasiliensis, Journal of General Microbiology, vol.20, pp.129-135, 1959. ,
C. legans as a model organism to investigate molecular pathways involved with Parkinson's disease. Developmental Dynamics: An Official Publication of the, American Association of Anatomists, vol.239, 2010. ,
URL : https://hal.archives-ouvertes.fr/hal-02431526
Parkinson's disease and pesticides: a toxicological perspective, Trends in Pharmacological Sciences, vol.29, 2008. ,
C. elegans: a practical approach, 1999. ,
URL : https://hal.archives-ouvertes.fr/hal-00313671
Identification of nocobactin NA biosynthetic gene clusters in Nocardia farcinica, Journal of Bacteriology, vol.193, 2011. ,
The complete genomic sequence of Nocardia farcinica IFM 10152, Proceedings of the National Academy of Sciences of the United States of America, vol.101, 2004. ,
Epidemiology of Parkinson's disease, 2007. ,
L-dopa-responsive movement disorder caused by Nocardia asteroides localized in the brains of mice, Infection and Immunity, vol.59, pp.181-191, 1991. ,
Circulating antibody to Nocardia in the serum of patients with Parkinson's disease, Advances in Neurology, vol.60, pp.355-357, 1993. ,
A genetic locus required for iron acquisition in Mycobacterium tuberculosis, Proceedings of the National Academy of Sciences of the United States of America, vol.103, pp.2069-2074, 2006. ,
,
Comprehensive research synopsis and systematic meta-analyses in Parkinson's disease genetics: the PDGene database, PLOS Genetics, vol.8, 2012. ,
Neuroprotective effects of the cultivated chondrus crispus in a C. legans model of Parkinson's disease, Marine Drugs, vol.13, pp.2250-2266, 2015. ,
Acetaminophen attenuates dopamine neuron degeneration in animal models of Parkinson's disease, Neuroscience Letters, vol.439, pp.129-133, 2008. ,
2017. C. legans as a model system to accelerate discovery for Parkinson disease, Current Opinion in Genetics & Development, vol.44, pp.102-109 ,
URL : https://hal.archives-ouvertes.fr/insu-01971899
Systemic exposure to proteasome inhibitors causes a progressive model of Parkinson's disease, Annals of Neurology, vol.56, 2004. ,
International Parkinson's Disease Genomics Consortium (IPDGC), Parkinson's Study Group (PSG) Parkinson's Research: the Organized GENetics Initiative (PROGENI), 23andMe, GenePD, NeuroGenetics Research Consortium (NGRC), Hussman Institute of Human Genomics (HIHG), vol.46, pp.989-993, 2014. ,